Shannon Campbell is of Black Diamond Therapeutics, Inc.. Currently has a direct ownership of 8,865 shares of BDTX, which is worth approximately $17,109. The most recent transaction as insider was on Dec 13, 2024, when has been sold 4,500 shares (Common Stock) at a price of $2.5 per share, resulting in proceeds of $11,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.87K
103.09% 3M change
n/a 12M change
Total Value Held $17,109

Shannon Campbell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2024
BUY
Grant, award, or other acquisition
$11,250 $2.5 p/Share
4,500 Added 33.67%
8,865 Common Stock
Sep 20 2024
BUY
Grant, award, or other acquisition
$11,252 $4.78 p/Share
2,354 Added 35.03%
4,365 Common Stock
Jun 21 2024
BUY
Grant, award, or other acquisition
$10,014 $4.98 p/Share
2,011 Added 50.0%
2,011 Common Stock
SC

Shannon Campbell

Cambridge, MA

Track Institutional and Insider Activities on BDTX

Follow Black Diamond Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BDTX shares.

Notify only if

Insider Trading

Get notified when an Black Diamond Therapeutics, Inc. insider buys or sells BDTX shares.

Notify only if

News

Receive news related to Black Diamond Therapeutics, Inc.

Track Activities on BDTX